Primary and secondary resistance in colorectal cancer
21 May 2012
Primary and secondary resistance in colorectal cancer
Heterogeneity of global cancer outcomes
Use of bio-banks in the EurocanPlatform
Highlights and goals of IMPAKT 2012
Endocrine therapy and endocrine resistant breast cancer
Minimising recurrence by using most effective treatment
Targeting the PI3K/mTOR pathway
Use of metformin against breast cancer
Criteria required before implementation of whole genome arrays in clinical practice
Innovation in molecular imaging
Effects of lifestyle change in cancer patients
Cervical cancer prevention through screening and vaccination